Most clients with DSM-5 diagnoses are being treated with a combination of psychological and pharmacological treatments. Newer drugs are being developed to treat mental disorders based on a better understanding of neurobiological contributions to mental disorders and the latest pharmacological research. To provide appropriate services, you are expected to have a thorough understanding of these common and complex issues. As a mental health professional, keeping up-to-date is essential.
This seminar will update and increase your knowledge of:
Neurobiological underpinnings of major DSM-5 diagnoses
Effects and side effects of drugs used to treat these diagnoses
Responsibilities of the non-prescribing therapist to clients taking psychiatric medication
Specifics of the pharmacological treatment and drugs of choice for Depressive, Bipolar, Schizophrenia Spectrum, Anxiety, OCD, Sleep-Wake, ADHD and Neurocognitive disorders will be presented. Unique to this webcast is information on the common types of psychotherapeutic drugs and other drugs that are abused, and methods for prevention and early detection. Throughout the day, representative case studies will generate discussion and examination of the latest drug treatment for DSM-5 disorders. You will leave this program with knowledge and confidence regarding effective and safe application of pharmacological drugs.
For more information: Customer Service
info@pesi.com
800-844-8260
To register: https://catalog.pesi.com/item/psychopharmacology-mental-health-professionals-125041
Approved for 6.25 CE hours in Diagnosis; no NBCC credits are available for this program
Share this page!